CIK: 0000315157 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 5, 2021
Total Value ($000): $2,175,975 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON (JNJ) | 12,610,000 | $2,077,371 | 95.5% | $59.66 | +142.9% | Common | 478160104 |
| OBDC | OWL ROCK CAPITAL CORP | 4,123,202 | $58,838 | 2.7% | $7.01 | +22.9% | Common | 69121K104 |
| RPRX | ROYALTY PHARMA PLC | 970,151 | $39,766 | 1.8% | $49.50 | -14.1% | Common | G7709Q104 |